Maplight Therapeutics holder plans sale of 152,230 shares

Maplight Therapeutics, Inc. shareholder Christopher Kroeger has filed to sell up to 152,230 common shares through broker Jefferies LLC, with an aggregate market value of 5,771,039.30, on or after July 15, 2026 on the NASDAQ market.

Rhea-AI Filing Summary

Maplight Therapeutics, Inc. shareholder Christopher Kroeger has filed to sell up to 152,230 common shares through broker Jefferies LLC, with an aggregate market value of 5,771,039.30, on or after July 15, 2026 on the NASDAQ market. The notice lists 42,620,000 common shares outstanding. It also details the acquisition history of the shares, including several Restricted Stock Unit grants from 2023 to 2025. In addition, it itemizes prior sales by Kroeger over the past three months, including a sale of 118,235 shares on May 18, 2026 for 3,215,511.97 and several smaller trades in April and May 2026.

Key Figures

Shares to be sold: 152230 shares Aggregate market value: 5771039.30 Shares outstanding: 42620000 shares +3 more

6 metrics

Shares to be sold 152230 shares Number of Maplight Therapeutics common shares covered by the planned sale

Aggregate market value 5771039.30 Aggregate market value of the 152,230 shares to be sold

Shares outstanding 42620000 shares Maplight Therapeutics common shares outstanding as referenced in the notice

Approximate sale date 07/15/2026 Planned date for sale of the covered shares on NASDAQ

Largest recent sale shares 118235 shares Shares sold by Christopher Kroeger on 05/18/2026

Largest recent sale proceeds 3215511.97 Gross proceeds from the 118,235-share sale on 05/18/2026

Key Terms

Restricted Stock Unit Grant, aggregate market value, Securities To Be Sold, Securities Sold During The Past 3 Months

4 terms

Restricted Stock Unit Grant financial

"Common | 05/02/2024 | Restricted Stock Unit Grant | Maplight Therapeutics, Inc."

aggregate market value financial

"152230 | 5771039.30 | 42620000 | 07/15/2026 | NASDAQ"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

Securities To Be Sold regulatory

"144: Securities To Be Sold Common | 05/02/2024 | Restricted Stock Unit Grant"

Securities Sold During The Past 3 Months regulatory

"144: Securities Sold During The Past 3 Months Christopher Kroeger"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Maplight Therapeutics (MPLT) shares are planned for sale under this notice?

The notice covers a planned sale of up to 152,230 common shares of Maplight Therapeutics, Inc. These shares are to be sold through broker Jefferies LLC on or after July 15, 2026 on the NASDAQ market.

What is the aggregate market value of the Maplight Therapeutics (MPLT) shares to be sold?

The planned sale has an aggregate market value of 5,771,039.30. This figure represents the total market value of the 152,230 Maplight Therapeutics common shares covered by the sale notice filed by shareholder Christopher Kroeger.

How many Maplight Therapeutics (MPLT) shares are outstanding according to this notice?

The notice states that there are 42,620,000 Maplight Therapeutics common shares outstanding. This figure provides context for the planned sale of 152,230 shares, showing the sale as a portion of the company’s total outstanding equity.

Who is the selling shareholder and broker in this Maplight Therapeutics (MPLT) transaction?

The selling shareholder is Christopher Kroeger, and the broker handling the transaction is Jefferies LLC. Jefferies LLC is identified with its New York address, and the shares are to be sold on the NASDAQ market.

What prior Maplight Therapeutics (MPLT) share sales are disclosed for the past 3 months?

The notice lists multiple sales by Christopher Kroeger between April 15 and May 18, 2026, including 118,235 shares sold on May 18, 2026 for 3,215,511.97, along with several smaller transactions in April and early May.

What types of acquisitions funded the Maplight Therapeutics (MPLT) shares being sold?

The shares trace back to several Restricted Stock Unit grants from 2023 to 2025. The notice lists RSU grants dated July 30, 2023, November 9, 2023, May 2, 2024, and July 18, 2025, each with associated share amounts acquired.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/15/2026 - 04:17 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001658918
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	MapLight Therapeutics, Inc.
SEC File Number	001-42914
Address of Issuer	800 CHESAPEAKE DRIVE REDWOOD CITY CALIFORNIA 94063
Phone	650-839-4360
Name of Person for Whose Account the Securities are To Be Sold	Kroeger Christopher A.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Jefferies LLC 520 Madison Avenue 4th Floor New York NY 10022	152230	5771039.30	42620000	07/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/02/2024	Restricted Stock Unit Grant	Maplight Therapeutics, Inc.			24223	05/02/2024	N/A
Common	11/09/2023	Restricted Stock Unit Grant	Maplight Therapeutics, Inc.			7664	11/09/2023	N/A
Common	07/30/2023	Restricted Stock Unit Grant	Maplight Therapeutics, Inc.			14845	07/30/2023	N/A
Common	07/18/2025	Restricted Stock Unit Grant	Maplight Therapeutics, Inc.			248925	07/18/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Christopher Kroeger 800 Chesapeake Drive Redwood City CA 94063	Common	05/18/2026	118235	3215511.97
Christopher Kroeger 800 Chesapeake Drive Redwood City CA 94063	Common	05/11/2026	13980	420966.60
Christopher Kroeger 800 Chesapeake Drive Redwood City CA 94063	Common	05/08/2026	34411	952905.28
Christopher Kroeger 800 Chesapeake Drive Redwood City CA 94063	Common	05/07/2026	20100	575774.55
Christopher Kroeger 800 Chesapeake Drive Redwood City CA 94063	Common	05/06/2026	23701	681645.26
Christopher Kroeger 800 Chesapeake Drive Redwood City CA 94063	Common	05/05/2026	10742	295283.80
Christopher Kroeger 800 Chesapeake Drive Redwood City CA 94603	Common	05/04/2026	15571	435312.69
Christopher Kroeger 800 Chesapeake Drive Redwood City CA 94603	Common	04/17/2026	10052	275140.33
Christopher Kroeger 800 Chesapeake Drive Redwood City CA 94063	Common	04/16/2026	10053	275167.70
Christopher Kroeger 800 Chesapeake Drive Redwood City CA 94063	Common	04/15/2026	9135	246020.99

144: Remarks and Signature

Remarks	Shares to be sold solely to satisfy tax-withholding obligations in connection w/RSU vesting
Date of Notice	07/15/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Christopher Kroeger
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)